Jullumstrø Eivind, Lydersen Stian, Møller Bjørn, Dahl Olav, Edna Tom-H
Department of Surgery, Levanger Hospital, Nord-Trøndelag Health Trust, N-7600 Levanger, Norway.
Eur J Cancer. 2009 Sep;45(13):2383-90. doi: 10.1016/j.ejca.2009.03.014. Epub 2009 Apr 6.
In colorectal cancer, the relation between duration of symptoms and stage at presentation and prognosis is not yet settled. All 1263 patients treated for colorectal cancer at Levanger Hospital, 1980-2004, and 2892 patients treated in Norway during 2004 were included. The association between symptom duration as an explanatory variable and tumour stage as a dependent variable was analysed using a proportional odds logistic regression model. Known duration of symptoms was divided into four categories: <1 week, 1-8 weeks, 2-6 months and >6 months. There was an inverse relationship between symptom duration and colon cancer TNM-stage, OR=0.73 (95% CI 0.63-0.84), p<0.001 (Levanger Hospital) and 0.84 (0.75-0.95), p=0.004 (Norway 2004), where the OR is per category of symptom duration. Duration of symptoms were also inversely associated with T-stage, N-stage and M-stage in colon cancer. These relationships were not found for rectal cancer. In colon cancer the relative five-year survival for the four intervals of symptom duration was 44%, 39%, 54% and 66%, p<0.001, in Levanger, 1980-2004, and four-year survival was 46%, 62%, 75% and 74%, p<0.001, in Norway 2004, respectively. For rectal cancer survival was not dependent on symptom duration. In a multivariate analysis of relative survival of patients with colon cancer, duration of symptoms was associated with survival independent of tumour differentiation and TNM-stage. Increasing duration of symptoms was positively associated with less advanced disease and better survival in colon cancer, but not in rectal cancer.
在结直肠癌中,症状持续时间与就诊时的分期及预后之间的关系尚未明确。纳入了1980年至2004年在莱万格医院接受结直肠癌治疗的所有1263例患者,以及2004年在挪威接受治疗的2892例患者。使用比例优势逻辑回归模型分析了作为解释变量的症状持续时间与作为因变量的肿瘤分期之间的关联。已知的症状持续时间分为四类:<1周、1 - 8周、2 - 6个月和>6个月。症状持续时间与结肠癌TNM分期呈负相关,比值比(OR)=0.73(95%置信区间0.63 - 0.84),p<0.001(莱万格医院),以及OR = 0.84(0.75 - 0.95),p = 0.004(2004年挪威),其中OR是针对每个症状持续时间类别而言。症状持续时间也与结肠癌的T分期、N分期和M分期呈负相关。直肠癌未发现这些关系。在莱万格,1980年至2004年期间,结肠癌症状持续时间四个区间的相对五年生存率分别为44%、39%、54%和66%,p<0.001;在2004年的挪威,四年生存率分别为46%、62%、75%和74%,p<0.001。对于直肠癌,生存率不依赖于症状持续时间。在对结肠癌患者相对生存率的多变量分析中,症状持续时间与生存率相关,且独立于肿瘤分化和TNM分期。症状持续时间的增加与结肠癌中病情进展较轻和生存率较高呈正相关,但直肠癌并非如此。